LSL-tdTom to generate PV-L-tdTom (PV-Cre;LSL-tdTom). Only heterozygous and hemizygous mice were used throughout the study to minimize the potential alteration of the phenotypes in mice carrying the transgene alleles 70 [47] . Mice were group-housed in a 12 h light-dark cycle. Food and water were provided ad libitum. All mice were maintained by backcrossing with C57BL/6J breeders (Jax 000664). The genotypes of all transgenic mice were determined by tail biopsy followed by PCR to identify the presence of the relevant transgenes. Both male and female mice were used in this study.
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Stereotaxic injections
Mice aged postnatal day 30-35 were anesthetized in an isoflurane induction chamber at 3-4% isoflurane and immobilized on a stereotaxic frame (David Kopf Instruments). Anesthesia was maintained using 1-2% isoflurane. The scalp was opened using a scalpel and a small craniotomy (1 mm diameter) was made with a dental drill (Osada). Viruses were infused with calibrated 5 µl glass pipettes (VWR) pulled to have a tip diameter 80 of 3 µm. The injection needle was left in situ for 5-10 min following the end of the injection to maximize tissue retention of AAV and decrease capillary spread upon pipette withdrawal. Experiments were performed 4-6 weeks after stereotaxic surgeries. The locations of the targeted injections were visually inspected under epifluorescence microscopy in ex vivo slices or histologically verified post hoc.
For in vivo ChR2 stimulation of PV + neurons or Npas1 + neurons, 90 nl of AAV9.EF1a.DIO.hChR2(H134R)-85 eYFP.WRE was injected into the GPe of PV-Cre or Npas1-Cre-tdTom mice. Alternatively, AAV9.EF1a.DIO.rev.EYFP.WPRE.SV40pA was injected into the GPe as a viral control. For in vivo GtACR2 inhibition of the GPe, 90 nl of AAV1.hSyn1.SIO.stGtACR2.FusionRed was injected in the GPe of PV-Cre or Npas1-Cre-tdTom mice. For in vivo GtACR2 inhibition of the subthalamic nucleus (STN) or dorsal striatum (dStr), 45 nl or 720 nl of AAV1.CKIIa.stGtACR2.FusionRed was injected into the STN or dStr of C57BL/6J mice, respectively. 90
For ex vivo electrophysiological recordings of STN inputs, 45 nl of AAV.Syn.ChR2(H134R).eYFP was injected unilaterally into the STN. For CreOn expression of ChR2 in the STN, 90 nl of AAV2.retro.DIO.CAG.tdTomato was injected at the substantia nigra pars reticulata (SNr) of the LSL-tdTom mice and 45 nl of AAV9.EF1a.DIO.ChR2(H134R).eYFP into the STN. For ex vivo electrophysiological recordings of other glutamatergic inputs, 90 nl of AAV.Syn.ChR2(H134R).eYFP was injected unilaterally into the 95 pedunculopontine nucleus (PPN) or parafascicular nucleus of the thalamus (PF Thal). A full listing of the viral constructs and titer information is available in Tables 1 and 2.
Fiber implantations and behavioral testing
In naïve mice, three weeks after stereotaxic injections, a fiber optic cannula was implanted bilaterally at the 100 region of interest ( Table 3) . Fiber cannulae with 0.63 NA, 400 µm core diameter (Prizmatix) and ceramic ferrule (Thorlabs) were prepared with non-fluorescent epoxy. Fibers that were measured to be 10 mW power at the tip were used for continuous stimulation; 15 mW power at the tip were used for 20 Hz pulse train stimulation.
Cannulae were fixed to the skull using dental cement (Parkell). The locations of the targeted implantations were histologically verified post hoc. 105 Behavior tests for in vivo optogenetics experiments were performed in an open field box (28 cm × 28 cm) between 2:00 pm and 7:00 pm. Testing was performed in a standard lit room. Experimental boxes were cleaned with 70% ethanol prior to experimentation and before subsequent tests to remove any scent clues.
Behavior tests for in vivo optogenetics were performed over the course of two consecutive days. On day one, each mouse was allowed to acclimate to the open-field box and the patch cord that is attached to the fiber 110 cannula for 20 min. On day two, movement data were collected as each mouse was allowed to move freely in the open-field arena. Movement data were collected with an overhead camera and EthoVision XT (Noldus). The position of the center of the body of each mouse was used to track movement parameters and data were sampled at the maximum sampling rate of the software (10 Hz). Each mouse was allowed to acclimate for five minutes at the beginning of the behavioral session. This was followed by stimulation trials using either a 115 continuous light pulse protocol or a pulse train (5 ms pulses at 20 Hz) protocol delivered for ten seconds with a one-minute intertrial interval. At least ten trials (60 s each) were run for any given protocol. Distance and velocity of movement were measured. The light stimulation period (referred to as "light") corresponds to 10 s of light delivery. "Pre" and "post" periods correspond to the 10-s epoch before and after light delivery, respectively.
Velocity values corresponding to pre, post, and light periods were measured by averaging the velocity during the 120 corresponding 10 s epochs. Fold change in activity was calculated from the motor activity during "light" vs. "pre".
To calculate normalized distance, data were normalized to the baseline activity measured from 25 s immediately before light. The median differences in movement velocity between "pre" and "light" and their 95% confidence intervals were estimated using the Estimation Stats application (https://www.estimationstats.com); five thousand bootstrap samples were taken; bias-corrected and accelerated (BC a ) corrections were applied to the 125 resampling bootstrap distributions to adjust for both bias and skewness [48] .
Chronic 6-OHDA lesion
To study the changes in the STN-GPe network in Parkinson's disease (PD) condition, the 6-hydroxydopamine (6-OHDA) lesion model of PD was used to achieve a chronic loss of dopamine neurons of the nigrostriatal system. 130 Unilateral 6-OHDA lesion was achieved by injecting 6-hydroxydopamine hydrochloride (6-OHDA, 2.5 μg/μl dissolved in 0.9% w/v NaCl with 0.1% w/v ascorbic acid) into the medial forebrain bundle ( Table 2 ) of the left hemisphere. Three weeks after the 6-OHDA injection, lesion success was determined by performing the cylinder task to assess forelimb use impairments. The ratio of ipsilateral to total forepaw touches was used to determine the success of lesion. In this task, during a five-minute exploratory behavioral assessment in a clear glass 135 cylinder, weight-bearing contacts made by each forepaw on the glass walls of the cylinder were manually quantified. Forelimb use asymmetry was determined by calculating left, right, and combined forepaw touches.
As impairment of the contralateral (i.e., right) forepaw was expected upon 6-OHDA lesion, a higher ratio of left to the sum of all touches indicates a more severe lesion. A ratio of 1.0 indicates that the mice only used left forelimb (ipsilateral to the lesion) for the entire test session. Mice with a ratio of forepaw touches less than 0.6 140 were considered poorly lesioned and were excluded from further experimental testing.
Ex vivo electrophysiological recordings
Mice aged postnatal day 60-90 (4-6 weeks after AAV and 6-OHDA injections) were anesthetized with a ketamine-xylazine mixture and perfused transcardially with ice-cold artificial CSF (aCSF) containing the 145 following (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 2.0 CaCl 2 , 1.0 MgCl 2 , 25 NaHCO 3 , and 12.5 glucose, bubbled continuously with carbogen (95% O 2 and 5% CO 2 ). The brains were rapidly removed, glued to the stage of a vibrating microtome (Leica Instruments), and immersed in ice-cold aCSF. Parasagittal slices (~13°) containing the GPe were cut at a thickness of 240 µm and transferred to a holding chamber, where they were submerged in aCSF with 3.33 mM pyruvate and 0.07 mM L-glutathione at 37°C for 30 min, and brought to room temperature 150 before recording. Slices were then transferred to a small volume (0.5 ml) Delrin recording chamber that was mounted on a fixed-stage, upright microscope (Olympus). As there is no clear demarcation between the GPe and the more ventral structures in ex vivo brain slices, only neurons in the dorsal two-thirds of the GPe were sampled for electrophysiological analyses. GPe neurons were visualized using differential interference contrast optics, illuminated at 735 nm (Thorlabs), and imaged with a 60× 1.0 NA water-immersion objective (Olympus) 155 and a CCD camera (QImaging). Genetically-labeled GPe neurons were identified based on their somatic tdTomato fluorescence and examined with epifluorescence microscopy using a white (6,500 K) LED (Thorlabs) and an appropriate filter cube (Semrock). The targeting of the eYFP signal of the fused ChR2 was assessed before each recording.
Recordings were made at room temperature (20-22 °C) with patch electrodes fabricated from capillary 160 glass (Sutter Instruments) pulled on a Flaming-Brown puller (Sutter Instruments) and fire-polished with a microforge (Narishige) immediately before use. Pipette resistance was typically 2-4 MOhms. The internal solution for cell-attached and voltage-clamp recordings of GPe neurons with STN stimulation consisted of the following (in mM): 125 CsMeSO 3 , 5 HEPES-K, 5 EGTA-K, 10 Na 2 -phosphoCreatine, 2 Mg 2 ATP, 0.5 CaCl 2 , 0.5 Na 3 GTP, 0.2% (w/v) biocytin, 5 tetraethylammonium chloride , 5 QX-314 Cl. SR95531 (10 µM) and CGP55845A 165 (1 µM) were included in the bath during recordings to block GABAergic transmission. The internal solution for anatomical analysis of STN-GPe contacts consisted of the following (in mM): 135 KMeSO 4 , 5 KCl, 0.5 CaCl 2 , 5 HEPES-K, 5 EGTA-K, 10 Na 2 Phosphocreatine, 2 Mg 2 ATP, 0.5 Na 3 GTP, 0.2% (w/v) biocytin. pH was adjusted to 7.25-7.30 with KOH; osmolarity was adjusted to 290 mOsm. The liquid junction potential for this internal solution was ~6 mV and was not corrected for. Somatic patch-clamp recordings were obtained with an amplifier 170 (Molecular Devices). The signal for all voltage-clamp recordings was filtered at 1 kHz and digitized at 10 kHz with a digitizer (Molecular Devices). For voltage-clamp recordings, series resistance was measured but not compensated for. The data were discarded if series resistance increased by 20% during recordings. Stimulus generation and data acquisition were performed using pClamp (Molecular Devices).
to prevent the disruption of intracellular milieu. The average spontaneous firing was measured after 2 minutes of stable firing activity. To measure the driven firing of GPe neurons, glutamatergic neuron terminals (from STN, PF Thal, or PPN) were optogenetically stimulated with 10 ms pulses at 10 Hz for 2 seconds. The average firing rate during the 2 second stimulation period was taken as the driven firing rates of the respective cells. Wholecell voltage-clamp recordings were used to measure excitatory postsynaptic currents (EPSCs). GPe neurons 180 were voltage-clamped at -50 mV and STN neuron terminals were optogenetically stimulated for 10 ms. The field of illumination used for stimulation was ~500 µm in diameter. To measure STN input without the topographical biasing of the STN fibers in the GPe, recordings were made from neighboring tdTomato + and tdTomatoneurons (less than 150 µm apart) in both PV-L-tdTom and Npas1-Cre-tdTom mice. To study STN input with CreOn expression of ChR2, EPSC recordings were made from tdTomato + and tdTomato -GPe neurons 185 in PV-L-tdTom mice. STN-GPe EPSCs were evoked by optogenetic stimulation; corticostriatal EPSCs were evoked with electrical stimulation [47] . To measure AMPA and NMDA receptor-mediated currents, the holding potential of recorded neurons was alternated between -80 mV and +40 mV. AMPA receptor-dependent currents were measured from the peak amplitude of EPCSs at -80 mV. NMDA receptor-dependent currents were measured at 50 ms after the EPSC peak at +40 mV. AMPA-NMDA ratio was calculated by dividing the AMPA 190 current to NMDA current.
Histology
Mice aged postnatal day 55-80 were anesthetized deeply with a ketamine-xylazine mixture and perfused transcardially first with 0.01 M PBS followed by a fixative containing 4% paraformaldehyde, pH 7.4. Brain tissue 195 was then postfixed in the same fixative for 2 h at 4°C. Tissue blocks containing the GPe were sectioned sagittally using a vibrating microtome (Leica Instruments) at a thickness of 60 µm. The sections were then washed, The area of the GPe (area), percentage of pixels within the GPe due to eYFP-labeled axons (% area), and the average gray value within the pixelated area (integrated density) were quantified using Fiji (http://fiji.sc/Fiji) [49] .
Brain tissue used for ex vivo electrophysiological recordings were stored in a 4% paraformaldehyde solution for 24 hours. PFA-fixed tissues were mounted on microscope slides, coverslipped with Prolong Gold antifade 205 mounting medium (Invitrogen), and imaged under an epifluorescence microscope (Keyence) to inspect the fluorescent signal from the site of viral injection. Results (3178 words)
Statistical analyses
PV + neurons and Npas1 + neurons play opposite roles in locomotion
We sought to dissect the relationship between GPe neuron activity and motor output with cell type-specific strategies. To confer transgene expression specificity in PV + neurons and Npas1 + neurons, we used CreOn 225 adeno-associated viruses (AAVs) in conjunction with PV-Cre and Npas1-Cre-tdTom mouse lines, respectively.
In vivo optogenetics, which provides a relatively high temporal resolution, was used to interrogate the roles that PV + neurons and Npas1 + neurons play in regulating locomotor activity. Stimulation of PV + neurons in vivo using ChR2 (an excitatory opsin) [52] induced an increase in spontaneous movement, as measured by velocity of locomotion during open-field activity (+83.99 ± 31.49%, n = 11 mice, P = 0.00098) (Figure 1a , Video 1). These 230 results were not due to phase-locking of PV + neuron activity from patterned activation of ChR2, as a sustained (10 s) light pulse was used. On the other hand, optogenetic stimulation with a 20 Hz train (10 s) was also effective in promoting motor output, arguing that the motor effects were not specific to the stimulation paradigms employed (+52.50 ± 19.52%, n = 11 mice, P = 0.00098; sustained vs train: P = 0.058). Moreover, these observations were not the result of non-specific effects of light delivery as PV-Cre mice infected with a control 235 virus (eYFP only) did not display any motor effects with light delivery (-7.09 ± 15.48%, n = 11 mice, P = 0.46) (Figure 1a ). [13, 36, 41, 42, 45, 53] . To confirm that the movement-promoting effects of PV + neuron stimulation were mediated through inhibiting these downstream targets, we optogenetically stimulated PV + neuron axon terminals in the STN (Figure 1b) and SNr. As expected, 240 stimulation of PV + axon terminals in either the STN or the SNr resulted in an increase in the velocity of movement (STN: +98 ± 20.20%, n = 6 mice, P = 0.0020; SNr: +57.72 ± 19.76%, n = 6 mice, P = 0.031). To mimic the inhibitory action of the GPe-STN input, we activated GtACR2 (an inhibitory opsin) [54] in STN neurons. As expected, we observed an increase in movement (+60.13 ± 16.42%, n = 10 mice, P = 0.0020) (Figure 1c , Video 2).
PV + neurons send inhibitory projections to the STN and SNr
In contrast with the motor effects of PV + neurons, in vivo optogenetic stimulation of Npas1 + neurons 245 induced a decrease in movement (sustained: -35.47 ± 10.24%, n = 16 mice, P = 0.00091) (Figure 2a, Video 3) .
Optogenetic stimulation of Npas1 + neurons with both a sustained light pulse and a 20 Hz-train were equally effective in suppressing motor output (train: -40.50 ± 10.09%, n = 16 mice, P = 0.00044; sustained vs train: P = 0.17). This observation is consistent with our previous findings with chemogenetic stimulation of Npas1 + neurons [55]. Importantly, our observations provide a causal demonstration of the proposed role of Npas1 + 250 neurons in movement suppression [35] . On the other hand, in vivo optogenetic inhibition of Npas1 + neurons using GtACR2 induced an increase in the movement (+34.24 ± 34.20%, n = 9 mice, P = 0.020) (Figure 2b) . Npas1-Cre-tdTom mice infected with a control AAV (eYFP only) did not display any motor effects with light delivery (-3.80 ± 10.60%, n = 9 mice, P = 0.73) (Figure 2a ). Npas1 + neurons primarily project to the dStr [29, 37, 38, 41, 42, 45]. As the dStr is responsible for motor behavior [56-58], we stimulated Npas1 + terminals within the dStr to 255 determine whether the movement-suppressing effects of stimulation of Npas1 + neurons are mediated through this downstream projection. Similar to the effects observed with somatic stimulation of Npas1 + neurons, optogenetic stimulation of their terminals in the dStr led to a reduction in movement (-22.29 ± 12.40%, n = 10 mice, P = 0.027) (Figure 2c ).
To confirm that the motor effects induced by optogenetic manipulation of GPe output were not a result 260 of experimental settings unique to our experimental setup, we optogenetically stimulated direct and indirect pathway striatal projection neurons (dSPNs and iSPNs, respectively) in the dStr. This resulted in a canonical increase (+73.81 ± 21.04%, n = 8 mice, P = 0.014) and decrease (-38.61 ± 7.70%, n = 8 mice, P = 0.031) in movement, respectively, as demonstrated previously [56] .
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The STN target is biased toward PV + neurons Our in vivo optogenetic interrogation showed that PV + neurons are movement-promoting and Npas1 + neurons are movement-suppressing. However, the excitatory inputs that naturally drive the activity of these GPe neurons have not been fully characterized. Both anatomical and physiological studies show that the principal glutamatergic input to the GPe arises from the STN [59-66]. However, it is not known whether the STN selectively 270 targets particular GPe neuron subpopulations. Computational models suggest that the STN targets a select subset of Npas1 + neurons [67]; however, this hypothesis was yet to be confirmed.
To study the properties of the STN-GPe input, we performed whole-cell, voltage-clamp recordings from genetically-identified PV + neurons and Npas1 + neurons in an acute brain slice preparation. To allow the stimulation of the STN input, an optogenetic approach was employed. Infection of the STN with an AAV that 275 expressed ChR2-eYFP constitutively led to robust ChR2-eYFP expression in STN neurons, including their axons within the GPe (Figure 3a) . In the presence of GABAergic antagonists (10 µM SR95531, 1 µM CGP55845), the properties of STN input were examined. Optogenetic stimulation of the STN input reliably evoked excitatory postsynaptic currents (EPSCs) in all neurons tested. Notably, EPSC amplitudes, as a measure of the STN input strength, were roughly five times larger in PV + neurons compared to those in Npas1 + neurons (PV + = 674.01 ± 12 174.47 pA, n = 34 neurons; Npas1 + = 128.30 ± 63.05 pA, n = 41 neurons; P < 0.0001) (Figure 3b & d) . The EPSCs evoked with the constitutive ChR2 expression were not due to ectopic infection of the zona incerta (ZI), which is immediately adjacent (dorsocaudal) to the STN, as selectively-targeted infection and optogenetic stimulation of the ZI input did not produce strong EPSCs in either PV + neurons or Npas1 + neurons to account for the strong biasing of STN input to PV + neurons over Npas1 + neurons (PV + : 33.93 ± 27.22 pA, n = 9 neurons; Npas1 + : 33.08 285 ± 20.39 pA, n = 9 neurons) (Figure 3c, d, & e ).
As the methodology employed did not rely on an STN-specific driver or promoter, a Cre-lox strategy was used as an alternative approach to demonstrate the specificity of the involvement of the STN in our analysis. To Our experiments collectively showed that the STN provides the primary 320 excitatory drive to GPe neurons, and that it is unique in its cell-targeting properties.
It is established that PV + neurons cluster in the dorsolateral regions of the GPe [41, 42, 45, 80]. In addition, anatomical tracing studies indicate that the STN input to the GPe is topographically organized [81, 82] . It is possible that the observed differences in the measured strength of input from STN to PV + neurons and to Npas1 + neurons were due to sampling bias across different spatial subdomains within the GPe. To this end, neighboring 325 tdTomato + and tdTomatoneurons (less than 150 µm apart) in both PV-L-tdTom (PV-Cre;LSL-tdTom) and
Npas1-Cre-tdTom mice were sampled. EPSC amplitudes in PV + neurons were consistently larger than those in PVneurons (PV + : 674.01 ± 174.47 pA, n = 34 neurons; PV -: 136.38 ± 60.94 pA, n = 12 neurons, P < 0.0001) (Figure 4d ). On the other hand, Npas1 + neurons had smaller EPSC amplitudes than Npas1neurons (Npas1 + :
128.30 ± 63.05 pA, n = 41 neurons; Npas1 -: 784.82 ± 191.25 pA, n = 16 neurons; P < 0.0001) (Figure 4d) . 330
STN-PV + input is weakened in PD
The STN-GPe network dysfunction in Parkinson's disease (PD) has been widely studied. The STN-GPe network shows abnormally synchronized oscillations in both patients and animal models of PD [83] [84] [85] . Critically, both STN lesioning and deep brain stimulation abolish these pathological oscillatory activities and have profound 335 therapeutic benefits in alleviating the motor symptoms of PD [83, 84, [86] [87] [88] [89] . Despite the clinical importance of the STN-GPe network, biophysical description of the alterations of the STN-GPe input in PD remains to be established. To this end, we examined the STN input to PV + neurons and Npas1 + neurons in the chronic 6-OHDA lesion model of PD. Similar to the observations in naïve mice, the STN input to PV + neurons was stronger than that to Npas1 + neurons in chronic 6-OHDA lesioned mice, as measured by EPSC amplitude. Importantly, STN 340 input to PV + neurons was selectively reduced in chronic 6-OHDA lesioned mice (469.12 ± 154.33 pA, n = 36 neurons, P < 0.0001) (Figure 4a-d, 5a & b) ; this difference was observed across a range of stimulation intensities (3-106 mW/mm 2 ). On the contrary, STN input to Npas1 + neurons did not show a detectable difference (113.28 ± 58.47 pA, n = 37 neurons, P = 0.91) (Figure 4a-d) .
The neuronal makeup of the STN is generally thought to be homogeneous [45, 90, 91] but see [59, 92-345 94] . Although single axons can display target cell-specific properties [95] [96] [97] , an alternative explanation for the differences in the STN input to PV + neurons and Npas1 + neurons in naïve mice and their alterations in chronic 6-OHDA lesioned mice could be due to cell-specific alterations in postsynaptic receptor properties. To this end, we biophysically-isolated AMPA and NMDA receptor-dependent currents to measure their relative contribution to the synaptic responses to STN input in PV + neurons and Npas1 + neurons. In addition, we compared this to a 350 well-studied glutamatergic synapse-the corticostriatal synapse (Figure 4e & f) . In naïve mice, both AMPA and NMDA receptor-mediated EPSCs in PV + neurons were larger than those in Npas1 + neurons (AMPA current: PV + = 685.06 ± 155.03 pA, n = 22 neurons; Npas1 + = 141.11 ± 45.53 pA, n = 18 neurons; P < 0.0001; NMDA current: PV + = 172.30 ± 54.26 pA, n = 22 neurons; Npas1 + = 62.19 ± 38.39 pA, n = 18 neurons, P < 0.0001) (Figure 4f &   g) . The AMPA-NMDA ratio of PV + neurons was also larger than that in Npas1 + neurons (PV + = 3.96 ± 0.82, n = 355 22 neurons; Npas1 + = 1.82 ± 0.45, n = 18 neurons; P < 0.0001). The AMPA-NMDA ratio of the STN-PV + input was larger than that observed at the corticostriatal synapse (dSPN = 3.09 ± 0.40, n = 10 neurons, P = 0.014; iSPN = 2.14 ± 0.52, n = 16 neurons; P < 0.0001) (Figure 4e & f) . The difference in the AMPA-NMDA ratio in PV + neurons and Npas1 + neurons indicates that different receptor complements mediate the transmission.
Both AMPA and NMDA receptor-mediated currents in PV + neurons were reduced in chronic 6-OHDA 360 lesioned mice compared to naïve mice (AMPA current = 430.79 ± 150.51 pA, n = 27 neurons, P = 0.00030; NMDA current = 116.94 ± 54.69 pA, n = 27 neurons, P = 0.024) (Figure 4f & g) . This appeared to be a coordinated regulation, as the AMPA-NMDA ratio was unchanged in chronic 6-OHDA lesioned mice (PV + = 3.62 ± 0.55, n = 27 neurons, P = 0.18; Npas1 + = 2.44 ± 0.71, n = 17 neurons, P = 0.68) (Figure 4f & g) . In contrast, AMPA and NMDA receptor-mediated currents were unchanged in Npas1 + neurons following chronic 6-OHDA lesion (AMPA 365 current = 122.07 ± 52.31 pA, n = 17 neurons, P = 0.73; NMDA current = 84.35 ± 33.69 pA, n = 17 neurons, P = 0.81) (Figure 4f & g) . These data are consistent with the downregulation of both AMPA and NMDA receptors in the GPe of PD models [98, 99] . Contrary to our prediction, we found an increase in the density of STN axonal fibers in the GPe in the chronic 6-OHDA lesioned mice (naïve = 74.84 ± 4.92%, n = 4 mice; 6-OHDA = 83.79 ± 4.56%, n = 7 mice; P = 0.0426) (Figure 5c & d) , suggesting that rather than a reduction in the innervations from 370 the STN, postsynaptic mechanisms were involved in the weakening of the STN input.
In light of the difference in the STN input to the two GPe neuron classes, we examined whether STN input also causes distinct changes in the activity of PV + neurons and Npas1 + neurons. We monitored the firing of GPe neurons in response to optogenetic stimulation of the STN input. Consistent with our prior work [41, 42], PV + neurons and Npas1 + neurons have distinct basal activity levels (PV + : baseline naïve = 18.26 ± 3.74 Hz, n = 23 375 neurons; Npas1 + : baseline naïve = 8.91 ± 2.97 Hz, n = 10 neurons; P < 0.0001) (Figure 6a & b) . In response to optogenetic stimulation of STN input, both PV + neurons and Npas1 + neurons showed increases in their firing (PV + : stim naïve = 51.48 ± 6.93 Hz, n = 23 neurons, P < 0.0001; Npas1 + : stim naïve = 31.68 ± 4.95 Hz, n = 10 neurons, P = 0.0020) (Figure 6a & b) . In naïve mice, the fold change in the firing of PV + neurons and Npas1 + neurons with STN stimulation was not significantly different (PV + naïve : 3.09 ± 0.90, n = 23 neurons; Npas1 + naïve : 3.87 ± 1.13, n = 380 10 neurons; P = 0.48). In 6-OHDA lesion, optogenetic stimulation of STN input also resulted in increases in the firing of PV + neurons and Npas1 + neurons (PV + : baseline 6-OHDA = 20.79 ± 2.97 Hz, stim 6-OHDA = 50.49 ± 9.90 Hz, n = 15 neurons, P < 0.0001; Npas1 + : baseline 6-OHDA = 5.94 ± 1.98 Hz, stim 6-OHDA = 16.83 ± 4.95 Hz, n = 11 neurons, P = 0.0010). Consistent with a weakening of the STN-PV + input, PV + neurons showed a selective reduction in the fold-increase of firing following a chronic 6-OHDA lesion (PV + : stim naïve = 3.09 ± 0.90, n = 23 neurons; stim 6-OHDA 385 = 2.38 ± 0.27, n = 15 neurons; P = 0.0049) (Figure 6a & b) . In contrast, Npas1 + neurons did not show a change in the fold-increase in their firing between naïve and chronic 6-OHDA lesion (Npas1 + : stim naïve = 3.87 ± 1.13, n = 10 neurons; stim 6-OHDA = 2.98 ± 0.96, n = 11 neurons; P = 0.24).
Stimulation of PV + neurons lessens hypokinetic symptoms 390
In agreement with the established relationship between STN activity and movement suppression [35, [100] [101] [102] [103] , both direct recordings and theoretical models assert that the hypokinetic symptoms of PD are a result of excessive STN activity [6, 15, [104] [105] [106] [107] [108] [109] [110] [111] . Importantly, lesioning and inactivation studies from animal models of PD further support this idea [112, 113] but see [114] . In other words, the weakening of the STN-PV + input that we observed in the chronic 6-OHDA lesioned mice ex vivo can thus be a form of homeostatic scaling in response to 395 the increased excitatory drive. However, this alteration may, in fact, be maladaptive as it would lead to decreased GPe feedback and thus disinhibition of the STN. If our interpretation is correct, then optogenetic stimulation of PV + neurons should restore motor activity in chronic 6-OHDA lesioned mice. Chronic 6-OHDA lesioned mice have reduced motor activity (naïve baseline = 2.74 ± 0.30 cm/s, n = 11 mice; 6-OHDA baseline = 1.42 ± 0.43 cm/s, n = 13 mice, P = 0.0073), as expected. Under this condition, ChR2-mediated stimulation of PV + neurons increased 400 locomotion in chronic 6-OHDA mice; the extent of the increase was comparable to that observed in naïve mice (83.69 ± 26.38%, n =13 mice, P = 0.70) (Figure 7a) . Moreover, stimulation of PV + neurons in 6-OHDA mice restored motor activity to the level as the baseline activity in naïve mice (naïve baseline = 2.74 ± 0.30 cm/s, n = 11 mice; 6-OHDA light = 2.62 ± 0.70 cm/s, n = 13 mice, P = 0.17).
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Discussion (1484 words)
Recent studies have shown that PV + neurons and Npas1 + neurons in the GPe form two near-exclusive, principal neuron classes that display molecular, electrophysiological, and anatomical dichotomy [14, [41] [42] [43] [44] . These findings led us to hypothesize that PV + neurons and Npas1 + neurons are embedded in distinct circuits. In this study, by optogenetically manipulating the activity of specific GPe neuron subpopulations and their downstream targets, we concluded that PV + neurons are movement-promoting and Npas1 + neurons are movementinhibiting.
GPe neuron subtypes have opposing roles in motor control
Early studies showed that GPe neurons change their activity in relation to movement; however, the identity of 415 the recorded neurons was unknown [11, 19, 22- In this study, we drove the activity of PV + neurons or Npas1 + neurons by activating ChR2. These experiments were critical to establishing the causal role of PV + neurons and Npas1 + neurons in motor control.
By directing light stimulus to different brain structures, we dissected the circuit elements that are involved in 435 these motor effects. While these gain-of-function experiments caused observable motor effects, they are insufficient to conclude if the motor effects are the native functions mediated by PV + neurons and Npas1 + neurons. We addressed this by performing loss-of-function experiments using GtCAR2 to inhibit GPe neuron subtypes or their postsynaptic targets. GPe neurons are known to form intranuclear collaterals [33, 123-125]. As we do not yet have the tools for the selective manipulation of these local collaterals, we will need to rely on ex 440 vivo studies to assess their relevance based on the connectivity principle of these local connections. In sum, our in vivo studies reinforce the notion from prior in vivo electrophysiological studies that GPe neurons are critical for movement. Importantly, we have now identified the circuit elements involved.
There are a number of possible explanations for the biological significance of PV + neurons and Npas1 + neurons. It is conceivable that the two neuron populations with opposing functions form a rheostat in controlling 445 net motor output. On the other hand, as both initiation and termination of motor programs are equally important [4, 5] , it is possible that PV + neurons and Npas1 + neurons are differentially involved in selecting voluntary versus suppressing competing motor programs. Alternatively, GPe neuron subtypes can be selectively engaged in the regulation of antagonistic muscle groups that are necessary for the execution of one specific movement. Similar ideas have been proposed for striatal neurons [8, [126] [127] [128] . To gain new insights into this topic, it will be 450 important in the future to determine the temporal organization of the activity of GPe neuron subtypes in relation to movement.
STN preferentially target PV + neurons
In this study, we found that the STN provides a stronger input to PV + neurons than to Npas1 + neurons. Our 455 finding contrasts with computational studies that predicted a stronger connection from the STN to a subset of Npas1 + neurons [67]. As we found a notable input from the STN to Npas1 + neurons, it is possible that the STN input regulates movement via sending an efferent copy to the Npas1 + neurons in addition to the primary projection to its downstream target, i.e., PV + neurons. Moreover, the difference in the AMPA-NMDA ratio of the synaptic responses in PV + neurons and Npas1 + neurons indicates that the STN input to these neurons is 460 mediated by different complements in the postsynaptic glutamate receptors. On the other hand, recent studies indicate the presence of heterogeneity in STN neurons [59, [92] [93] [94] 129] . It is possible that unique STN neurons provide inputs to distinct GPe neuron subpopulations. As we are only beginning to grasp the cellular heterogeneity within both the GPe and STN, additional work is needed to further our understanding of the organization of the STN-GPe network. As PV + neurons form the principal inhibitory innervation to the STN [36, 465 37, 42, 45], these data collectively demonstrate a closed reciprocal feedback loop formed between the STN and PV + neurons. Although earlier studies have examined the electrophysiological and anatomical properties of STN-GPe network [13, 36, 37, 42, 45, 62, 66, 76, 130, 131] , the cell-type specificity of the STN input in the GPe was not known. Importantly, our new data added critical insights into the cellular constituents that are involved in this reciprocal loop. 470
We found that in addition to the STN, the PF Thal and PPN provide excitatory inputs to the GPe. However, our ex vivo data showed that not all GPe neurons responded to the stimulation of PF Thal and PPN inputs. This heterogeneity existed in both PV + neurons and Npas1 + neurons. Although it is possible that inputs from PF Thal and PPN target specific subpopulations of GPe neurons, a systematic examination will be required to test if the observed heterogeneity correlates with the expression of subclass-specific molecular markers in GPe neurons. 475
In addition, we, and others, have shown that the cortex is another major source of excitatory input to the GPe [41, 53, 77, 132, 133] . However, the properties of this input remain to be fully characterized. It will be important to further examine the properties of the corticopallidal projection, including their alterations in models of PD.
The STN-GPe network is important in health and in PD 480
In this study, we found that the STN input to PV + neurons is reduced in chronic 6-OHDA lesioned mice. These findings are consistent with the downregulation of AMPA and NMDA receptors in the GPe of PD models [98, 99] .
We have previously found a decrease in the ambient glutamate content in the GPe following a chronic loss of dopamine [134]; our current study adds to the literature that glutamatergic signaling in the GPe is altered in PD.
STN-GPe network function and its dysfunction in the context of PD have been widely studied. 485
Experimental and computational studies suggest that the STN-GPe network acts as an intrinsic oscillator [135] [136] [137] [138] . Abnormally synchronized beta oscillations (i.e., 15-30 Hz) in the STN-GPe network are thought to be partially responsible for the hypokinetic symptoms of PD [15, 84, 108, 139] . Abolishing the pathological oscillatory activity by lesioning or deep-brain stimulation of the STN or the GPe has profound therapeutic benefits in alleviating motor symptoms of PD [86] [87] [88] . We previously observed strengthening of the GABAergic 490 GPe input to the STN with chronic 6-OHDA lesion [140] ; it is now clear that this input arises from PV + neurons as PV + neurons are the primary source of inhibitory input to the STN [36, 41, 42] . As the activity of the STN negatively regulates motor output [35, 100, 101] , a decrease in the ambient glutamate content in the GPe [134], along with a reduction in the STN-PV + input, would disinhibit the STN and suppress motor output in the parkinsonian state, thus explaining the hypokinetic symptoms of PD. On the other hand, a strengthening of the inhibitory PV + input 495 to the STN [141] would promote movement and may act as a compensatory mechanism against the hypokinetic effects of the abnormal glutamatergic signaling in the GPe in PD. How these synaptic adaptations interact and impact pathological, correlated activity patterns in the STN-GPe is yet to be fully understood [142] . In the future, it will be important to understand the exact mechanism through which dopamine loss results in the cellular alterations in the STN-GPe network. 
Figure Legends
